Regulation of Decay Accelerating Factor Primes Human Germinal Center B Cells for Phagocytosis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 27 08 2020
accepted: 13 11 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 17 6 2021
Statut: epublish

Résumé

Germinal centers (GC) are sites for extensive B cell proliferation and homeostasis is maintained by programmed cell death. The complement regulatory protein Decay Accelerating Factor (DAF) blocks complement deposition on host cells and therefore also phagocytosis of cells. Here, we show that B cells downregulate DAF upon BCR engagement and that T cell-dependent stimuli preferentially led to activation of DAF

Identifiants

pubmed: 33469456
doi: 10.3389/fimmu.2020.599647
pmc: PMC7813799
doi:

Substances chimiques

CD55 Antigens 0
PRDM1 protein, human 138415-26-6
Positive Regulatory Domain I-Binding Factor 1 EC 2.1.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

599647

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI142777
Pays : United States

Informations de copyright

Copyright © 2021 Dernstedt, Leidig, Holm, Kerkman, Mjösberg, Ahlm, Henriksson, Hultdin and Forsell.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Blood. 2012 Sep 13;120(11):2240-8
pubmed: 22740445
Immunol Rev. 2016 Nov;274(1):218-232
pubmed: 27782329
EMBO J. 1995 Nov 15;14(22):5579-88
pubmed: 8521815
Cell. 1994 Apr 22;77(2):297-306
pubmed: 8168136
Nat Immunol. 2015 Sep;16(9):907-17
pubmed: 26287597
Br J Cancer. 1972 Aug;26(4):239-57
pubmed: 4561027
Science. 2017 Oct 13;358(6360):
pubmed: 28935768
J Exp Med. 1969 Dec 1;130(6):1367-93
pubmed: 4900926
Annu Rev Med. 1957;8:239-56
pubmed: 13425332
J Virol. 2008 May;82(9):4257-64
pubmed: 18305044
J Exp Med. 2000 Jan 17;191(2):253-64
pubmed: 10637270
Immunity. 2017 Dec 19;47(6):1142-1153.e4
pubmed: 29262350
PLoS One. 2014 Nov 17;9(11):e113388
pubmed: 25401487
N Engl J Med. 2017 Jul 6;377(1):52-61
pubmed: 28657829
J Immunol. 2018 Apr 15;200(8):2882-2893
pubmed: 29540581
Science. 1997 Apr 25;276(5312):596-9
pubmed: 9110979
Dev Immunol. 1998;6(3-4):285-94
pubmed: 9814602
Nat Immunol. 2011 Jun;12(6):536-43
pubmed: 21572431
J Immunol. 2018 Jun 1;200(11):3691-3696
pubmed: 29686051
Proc Natl Acad Sci U S A. 1984 May;81(10):3180-4
pubmed: 6203114
Int J Gen Med. 2019 Sep 16;12:343-351
pubmed: 31571973
Nature. 2004 Jun 3;429(6991):566-71
pubmed: 15152264
Blood. 2000 Nov 15;96(10):3522-8
pubmed: 11071650
Cell Biosci. 2017 May 30;7:29
pubmed: 28572915
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Blood. 2017 Jan 19;129(3):347-357
pubmed: 27903527
Cell. 2000 Sep 1;102(5):553-63
pubmed: 11007474
Annu Rev Immunol. 2012;30:429-57
pubmed: 22224772
Nat Immunol. 2012 Nov;13(11):1092-100
pubmed: 23001146
Clin Microbiol Rev. 2010 Apr;23(2):412-41
pubmed: 20375360
Blood. 2011 Jul 28;118(4):1008-14
pubmed: 21652682
Immunity. 2001 Feb;14(2):169-79
pubmed: 11239449
CA Cancer J Clin. 1976 Mar-Apr;26(2):119-21
pubmed: 816431
Immunology. 1987 Nov;62(3):405-11
pubmed: 3499379
Kidney Int. 1986 Dec;30(6):932-6
pubmed: 3546915
Cell. 1993 May 21;73(4):703-11
pubmed: 8500164
J Exp Med. 2017 Apr 3;214(4):1181-1198
pubmed: 28351982
J Immunol. 2004 Oct 1;173(7):4260-4
pubmed: 15383553
Eur J Immunol. 2002 May;32(5):1359-67
pubmed: 11981823
Cell Death Differ. 2016 Jun;23(6):915-26
pubmed: 26990661
Immunity. 2016 Sep 20;45(3):471-482
pubmed: 27653600
Tissue Antigens. 2013 Jul;82(1):26-34
pubmed: 23692281
Cell. 1991 Dec 20;67(6):1121-9
pubmed: 1760840
Cold Spring Harb Symp Quant Biol. 1999;64:211-6
pubmed: 11232288
Nature. 1989 Dec 21-28;342(6252):929-31
pubmed: 2594086
J Exp Med. 2011 Jun 6;208(6):1243-52
pubmed: 21576382
J Cell Biol. 1963 Dec;19:641-6
pubmed: 14086143
J Immunol. 1991 Apr 1;146(7):2345-51
pubmed: 1706395
Immunity. 2012 Aug 24;37(2):199-207
pubmed: 22921118
J Immunol. 2004 May 1;172(9):5427-40
pubmed: 15100284

Auteurs

Andy Dernstedt (A)

Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.

Jana Leidig (J)

Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.

Anna Holm (A)

Department of Clinical Sciences, Division of Otorhinolaryngology, Umeå University, Umeå, Sweden.

Priscilla F Kerkman (PF)

Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.

Jenny Mjösberg (J)

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Clas Ahlm (C)

Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.

Johan Henriksson (J)

Molecular Infection Medicine Sweden, Department of Molecular Biology, Umeå University, Umeå, Sweden.

Magnus Hultdin (M)

Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.

Mattias N E Forsell (MNE)

Department of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH